Mostrando 641 - 660 Resultados de 58,773 Para Buscar '"Her"', tiempo de consulta: 0.28s Limitar resultados
  1. 641
  2. 642
    “…METHODS: We present a framework for assessing the appropriateness of extrapolation using trastuzumab, an anti-HER2 antibody, for HER2-amplified tumors where trastuzumab use would be off-label as an illustrative example. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 643
    “…BACKGROUND: Human epidermal growth factor receptor 2 (HER2) low breast cancer was considered as a distinct subtype different from HER2-zero breast cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 644
  5. 645
    “…SIMPLE SUMMARY: We conducted the Neo-LaTH study in which patients with HER2-positive breast cancer were randomized to different lengths of neoadjuvant induction anti-HER2 therapy with lapatinib and trastuzumab followed by weekly paclitaxel plus anti-HER2 therapy, and in estrogen receptor-positive patients, with or without concurrent endocrine therapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 646
    Publicado 2009
    Libro
  7. 647
  8. 648
    “…Pauline Gagnon presented her book "Qu'est-ce que le boson de Higgs mange en hiver et autres détails essentiels" to a most excited audience in the CERN Library. …”
    Enlace del recurso
  9. 649
    por Rowe, David E, Koreuber, Mechthild
    Publicado 2020
    “…Drawing on original archival material and recent research, this book follows Emmy Noether’s career from her early years in Erlangen up until her tragic death in the United States. …”
    Enlace del recurso
    Enlace del recurso
  10. 650
    “…From this point of view, the detection of new potential therapeutic targets such as HER2 is particularly interesting. In this study, we demonstrated that overexpression of HER2 (++ or +++) was present in 31.4% of p53-mutated endometrial carcinomas and that among these, 36.3% showed amplification of the HER2 gene by CISH (Chromogenic In Situ Hybridization). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 651
  12. 652
    “…SIMPLE SUMMARY: HER2-positive breast cancer (BC), which accounts for ~20% of BC, is one of the more aggressive and has the worst overall survival rate among them. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 653
    por Hou, Yanjun, Nitta, Hiroaki, Li, Zaibo
    Publicado 2023
    “…SIMPLE SUMMARY: HER2 intratumoral heterogeneity (ITH) is a well-known phenomenon in breast cancer, defined as the coexistence of subpopulations of tumor cells with different HER2 gene or protein expression within a tumor. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 654
  15. 655
  16. 656
  17. 657
    “…Neratinib as a tyrosine kinase inhibitor can prevent the transduction of HER1, HER2 and HER4 signaling pathways thus playing an anticancer effect. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 658
    “…Somatic HER2 mutations are a novel class of therapeutic targets across different cancer types. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 659
  20. 660
Herramientas de búsqueda: RSS